FDA approves gene therapy sickle cell treatment

FDA’s Efforts to Advance the Development and Approval of Cellular and Gene Therapies

FDA approves first gene therapy for sickle cell disease

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series

FDA approves first gene therapies to treat patients with sickle cell disease

Cell & gene therapies more likely to receive FDA approval: ARM Studios interview with Mark Trusheim

Sickle Cell Disease Quality Measurement Town Hall

A New FDA-Approved Gene Therapy Helps Treat a Rare Childhood Cancer

75th Cellular, Tissue, and Gene Therapies Advisory Committee

The First CRISPR Gene Therapy Is Here

Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’

Gene Therapy Inside Out

Navigating regulatory challenges for cell and gene therapy products in 2024 and beyond

FDA approves gene therapies to treat Sickle Cell Disease

FDA approves Novartis gene therapy for rare genetic disorder

FDA approves gene editing treatments that may cure sickle cell

MEDIA CALL: FDA Approves First Gene Therapies to Treat Sickle Cell Disease – 12/08/2023

FDA approves first gene therapies for sickle cell disease

US FDA approves 2 sickle cell gene therapies in medical breakthrough

Advanced Topics Successful Development of Quality Cell and Gene Therapy Products